About Saladax
Saladax is a company based in Bethlehem (United States) founded in 2004 by Salvatore J Salamone. Saladax has raised $46.32 million across 6 funding rounds from investors including Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners. Saladax offers products and services including 5-Fluorouracil Assay and Clozapine Assay. Saladax operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Bethlehem, United States
- Founders Salvatore J Salamone
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Saladax Biomedical, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$46.32 M (USD)
in 6 rounds
-
Latest Funding Round
$22.93 M (USD), Series D
Sep 05, 2013
-
Investors
Fosun Pharmaceutical
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Saladax
Saladax offers a comprehensive portfolio of products and services, including 5-Fluorouracil Assay and Clozapine Assay.
Monitors chemotherapy drug levels for optimal patient dosing
Assesses psychiatric medication levels to ensure effective treatment
People of Saladax
Unlock access to complete
Unlock access to complete
Funding Insights of Saladax
Saladax has successfully raised a total of $46.32M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $22.93 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Saladax
Saladax has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused VC Firm investing in the US
|
Locked | Locked | Locked | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Locked | Locked | Locked | |
|
Early to late stage VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Saladax
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Saladax
Investment portfolio details for Saladax
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Saladax
Detailed financials for Saladax
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Saladax Comparisons
Peer comparison for Saladax
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Saladax
Saladax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
Detailed competitors of Saladax
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Saladax
Complete news archive for Saladax
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saladax
Saladax was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Saladax is headquartered in Bethlehem, United States.
Salvatore J Salamone is the current CEO of Saladax. They have also founded this company.
Saladax is a funded company, having raised a total of $46.32M across 6 funding rounds to date.
Founded in 2004 and based in Bethlehem, United States, Saladax Biomedical operates in the oncology sector. MyCare diagnostic blood tests are developed and offered to enable individualized chemotherapy dosing for patients. This approach is intended to enhance treatment outcomes while minimizing toxic side effects. Companion diagnostics are co-developed with pharmaceutical companies to support drug efficacy in clinical development.
Saladax's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
Saladax offers 5-Fluorouracil Assay and Clozapine Assay.
Saladax has 6 investors. Key investors include Fosun Pharmaceutical, GE Capital, Ben Franklin Technology Partners, Golden Seeds, and Excel Venture Management.